Today’s trading update highlights +35% YoY net services revenue growth in 2017, with a particularly strong performance by the Data Safety & Medical Information division, only partially offset (as previously reported) by lower reimbursement revenue. Although net H2 revenue was marginally below our forecasts as a result of clinical trial deferrals, the strong Services order book (£88m at period-end, up from just over £70m at the H1 stage) bodes well for continued strong growth in 2018 and beyond. ....
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
FY trading update: strong top-line growth & order book expansion
- Published:
25 Jan 2018 -
Author:
Sheena Berry -
Pages:
3
Today’s trading update highlights +35% YoY net services revenue growth in 2017, with a particularly strong performance by the Data Safety & Medical Information division, only partially offset (as previously reported) by lower reimbursement revenue. Although net H2 revenue was marginally below our forecasts as a result of clinical trial deferrals, the strong Services order book (£88m at period-end, up from just over £70m at the H1 stage) bodes well for continued strong growth in 2018 and beyond. ....